Fredun Pharmaceuticals Limited, one of the leading formulations Company in India, today announced a $3.2 Million (INR 22 crore) order for the sales of cardiac and anti-infectives to East African countries. The order will be executed over a period of 16 months.
Commenting on the order, Mr. Fredun Medhora, Managing Director, Fredun Group said, "We are pleased to share this milestone development, which is one of the largest single orders for the Company. This order strengthens our position in the East African region, thereby reinforcing our commitment to improving the lives of people."
Shares of Fredun Pharmaceuticals Limited was last trading in BSE at Rs. 462.1 as compared to the previous close of Rs. 393.05. The total number of shares traded during the day was 132811 in over 2506 trades.
The stock hit an intraday high of Rs. 471.65 and intraday low of 382.6. The net turnover during the day was Rs. 58390629.